Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of interstitial cystitis/painful bladder syndrome

Reviews on Recent Clinical Trials

Volumn 3, Issue 2, 2008, Pages 126-129

  Porru, Daniel ^a   Cervigni, M ^b   Nasta, L ^c   Natale, F ^b   Voi, R Lo ^b   Tinelli, C ^a   Gardella, B ^a   Anghileri, A ^a   Spinillo, A ^a   Rovereto, B ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c Mangiagalli e Regina Elena   (Italy)

Author keywords

Chondroitine sulfate; Hyaluronic acid; Interstitial cystitis; Intravesical treatment; Painful bladder syndrome

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; SODIUM CHLORIDE; IMMUNOLOGICAL ADJUVANT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION; MULTICENTER STUDY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY URGENCY; URINE VOLUME; VISCOSITY; VISUAL ANALOG SCALE; AGED; DRUG COMBINATION; INTRAVESICAL DRUG ADMINISTRATION; MIDDLE AGED; PAIN ASSESSMENT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; CHONDROITIN SULFATES; CYSTITIS, INTERSTITIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYALURONIC ACID; MIDDLE AGED; PAIN MEASUREMENT; TREATMENT OUTCOME; VISCOSITY;

EID: 46749158369     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488708784223817     Document Type: Article

References (15)

1. Hanno P. Interstitial cystitis and related disorders. In: Walsh P, Ed. Campbell's Urology. 8th ed. Philadelphia: Elsevier 2002; pp. 631.
2. Morales A, et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 1996; 156: 45-8.
3. Nordling J, et al. Cystistat for the treatment of interstitial cystitia: a 3-year follow-up study. Urology 2001; 57(6 Suppl 1): 123.
4. Boucher WS, et al. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 2002; 167: 380-4.
5. Palylyk-Colwell E. Chondroitin sulphate for interstitial cystitis. Issues Emerg Health Technol 2006, 86: 1-4.
6. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988; 140: 203.
7. Bernie JE, et al. The intravesical potassium sensitivity test and urodynamics: implications in a large cohort of patients with lower urinary tract symptoms. J Urol 2001; 166(1): 158-61.
8. O'Leary MP, et al. The Interstitial Cystitis Symptom Index and Problem Index. Urology 1997; 49 (suppl 5A): 58-63.
9. Minaglia S, et al. Validation of Spanish version of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Urology 2005; 65(4): 664-9.
10. Oberpenning F, et al. Interstitial cystitis: an Update. Curr Opin Urol 2002; 12 (4): 321-32.
11. Porru D, et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 1997; 59: 26-9.
12. Iavazzo C, et al. Hyaluronic Acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis. Eur Urol 2007; 51(6): 1534-41.
13. Balasz EA, Denlinger JL. The role of hyaluronic acid in arthritis and its therapeutic use. In: Osteoarthritis: Current Clinical and Fundamental Problems. Peyron JG. Ed Basel: Geigy, 1984; pp. 165-74.
14. Hanno P. Interstitial cystitis and related diseases. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ Eds. Campbell's Urology, 7th ed. Philadelphia: WB Saunders, Co vol.1, sect IV, chapt 17, 1998; pp. 631-62.
15. Goldberg RL, Toole BP. Hyaluronate inhibition of cell proliferation. Arth Rheum 1987; 30: 769.